HDFC Bank Share Sale

Several benches of the Bombay High Court have recused from hearing HDFC Bank CEO and MD Sashidhar Jagdishan's plea to quash an FIR of cheating and fraud registered against him on a complaint filed by the Lilavati Kirtilal Mehta Medical Trust. While some judges cited having worked with either the Trust or the lawyers appearing for it, one judge on Thursday voluntarily disclosed that he held few shares of the HDFC Bank. Senior counsel Amit Desai appearing for Jagdishan said they do not have an objection with the same but counsel Niteen Pradhan appearing for the Trust took an objection. Pursuant to this, the bench of Justices M S Sonak and Jitendra Jain recused and said the matter shall be placed before another bench. According to the complaint filed by the Trust, which owns and manages the prominent Lilavati Hospital in Mumbai, Jagdishan allegedly accepted a bribe of Rs 2.05 crore in exchange for providing financial advice to help the Chetan Mehta Group retain illegal and undue ...

However, HDFC Bank seems to have bottomed out in mid-February when it hit a 52-week low of Rs 1,363

US-based Bernstein slashes rating to underweight, almost halves target price; UBS maintains positive stance

HDFC Bank has a price-to-book multiple of 5.16, making it the most expensive among lenders across the globe with at least $50 billion in market value